Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Iris International Inc (IRI) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Iris International Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 319240.
Total stock buying since 2010: $152,028.
Total stock sales since 2010: $7,026,265.
Total stock option exercises since 2010: $11,183,573.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2012 | 800 | $9,992 | 351,777 | $6,448,507 | 1,016,041 | $10,919,700 |
| 2011 | 0 | $0 | 53,890 | $482,146 | 120,371 | $263,873 |
| 2010 | 17,000 | $142,036 | 12,500 | $95,612 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2012-10 | 0 | $0 | 301,300 | $5,875,348 | 941,441 | $10,620,628 |
| 2012-09 | 0 | $0 | 0 | $0 | 4,402 | $0 |
| 2012-08 | 0 | $0 | 0 | $0 | 5,652 | $0 |
| 2012-06 | 0 | $0 | 0 | $0 | 4,398 | $0 |
| 2012-05 | 0 | $0 | 20,000 | $222,200 | 20,000 | $60,199 |
| 2012-03 | 800 | $9,992 | 20,536 | $247,667 | 30,207 | $208,952 |
| 2012-02 | 0 | $0 | 1,941 | $23,292 | 1,941 | $5,842 |
| 2012-01 | 0 | $0 | 8,000 | $80,000 | 8,000 | $24,079 |
| 2011-12 | 0 | $0 | 0 | $0 | 87,797 | $223,873 |
| 2011-11 | 0 | $0 | 0 | $0 | 3,807 | $0 |
| 2011-09 | 0 | $0 | 0 | $0 | 1,002 | $0 |
| 2011-08 | 0 | $0 | 8,890 | $74,516 | 2,753 | $0 |
| 2011-06 | 0 | $0 | 25,000 | $229,870 | 1,004 | $0 |
| 2011-05 | 0 | $0 | 20,000 | $177,760 | 20,000 | $40,000 |
| 2011-03 | 0 | $0 | 0 | $0 | 4,008 | $0 |
| 2010-12 | 1,000 | $9,673 | 0 | $0 | 0 | $0 |
| 2010-11 | 4,500 | $44,325 | 0 | $0 | 0 | $0 |
| 2010-08 | 11,500 | $88,038 | 12,500 | $95,612 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-10-31 | O'leary Richard A. (Corp. VP, HR & Admin) | Sale | 3,944 | 19.50 | 76,908 |
| 2012-10-31 | O'leary Richard A. (Corp. VP, HR & Admin) | Option Ex | 8,437 | 10.32 | 87,069 |
| 2012-10-31 | Ginsburg Philip (Corporate VP and CMO) | Sale | 16,149 | 19.50 | 314,905 |
| 2012-10-31 | Ginsburg Philip (Corporate VP and CMO) | Option Ex | 35,090 | 9.45 | 331,425 |
| 2012-10-31 | Karlan Beth Y (Director) | Sale | 19,278 | 19.50 | 375,921 |
| 2012-10-31 | Karlan Beth Y (Director) | Option Ex | 42,731 | 11.65 | 497,687 |
| 2012-10-31 | Warekois Tom E (Corp VP, Pres IRIS Diagnostics) | Sale | 30,296 | 19.50 | 590,772 |
| 2012-10-31 | Warekois Tom E (Corp VP, Pres IRIS Diagnostics) | Option Ex | 100,731 | 10.65 | 1,072,382 |
| 2012-10-31 | Wasserman Stephen Edward (Director) | Sale | 16,482 | 19.50 | 321,399 |
| 2012-10-31 | Wasserman Stephen Edward (Director) | Option Ex | 51,886 | 13.42 | 696,206 |
| 2012-10-31 | Yi John U (Corp VP, Operations) | Sale | 24,250 | 19.50 | 472,875 |
| 2012-10-31 | Yi John U (Corp VP, Operations) | Option Ex | 78,978 | 10.65 | 840,799 |
| 2012-10-31 | Della Penta David T (Director) | Sale | 13,796 | 19.50 | 269,022 |
| 2012-10-31 | Della Penta David T (Director) | Option Ex | 27,736 | 10.73 | 297,690 |
| 2012-10-31 | Mello Robert A (Corp VP/Pres Sample Processing) | Sale | 25,695 | 19.50 | 501,052 |
| 2012-10-31 | Mello Robert A (Corp VP/Pres Sample Processing) | Option Ex | 78,978 | 10.65 | 840,799 |
| 2012-10-31 | Garcia Cesar M (President and CEO) | Sale | 65,139 | 19.50 | 1,270,210 |
| 2012-10-31 | Garcia Cesar M (President and CEO) | Option Ex | 255,436 | 10.65 | 2,719,371 |
| 2012-10-31 | Timmins Rick (Director) | Sale | 12,316 | 19.50 | 240,162 |
| 2012-10-31 | Timmins Rick (Director) | Option Ex | 31,957 | 12.26 | 391,728 |
| 2012-10-31 | Adams Thomas Phd (CTO & Corporate V.P.) | Sale | 23,766 | 19.50 | 463,437 |
| 2012-10-31 | Adams Thomas Phd (CTO & Corporate V.P.) | Option Ex | 82,023 | 12.86 | 1,054,651 |
| 2012-10-31 | Khalifa Amin I (CFO and Corporate V.P. Finance) | Sale | 19,963 | 19.50 | 389,278 |
| 2012-10-31 | Khalifa Amin I (CFO and Corporate V.P. Finance) | Option Ex | 51,945 | 9.85 | 511,658 |
| 2012-10-31 | Besbeck Steven M (Director) | Sale | 14,308 | 19.50 | 279,006 |
| 2012-10-31 | Besbeck Steven M (Director) | Option Ex | 41,886 | 12.96 | 542,758 |
| 2012-10-31 | Voboril Edward F (Director) | Sale | 15,918 | 19.50 | 310,401 |
| 2012-10-31 | Voboril Edward F (Director) | Option Ex | 53,627 | 13.73 | 736,405 |
| 2012-09-30 | O'leary Richard A. (Corp. VP, HR & Admin.) | Option Ex | 563 | .00 | 0 |
| 2012-09-30 | Ginsburg Philip (Corp. VP, CMO) | Option Ex | 806 | .00 | 0 |
| 2012-09-30 | Warekois Tom E (Corp VP, Pres IRIS Diagnostics) | Option Ex | 808 | .00 | 0 |
| 2012-09-30 | Yi John U (Corp VP, Operations) | Option Ex | 490 | .00 | 0 |
| 2012-09-30 | Mello Robert A (Corp VP/Pres Sample Processing) | Option Ex | 490 | .00 | 0 |
| 2012-09-30 | Adams Thomas Phd (CTO & Corporate V.P.) | Option Ex | 293 | .00 | 0 |
| 2012-09-30 | Khalifa Amin I (CFO and Corporate V.P. Finance) | Option Ex | 952 | .00 | 0 |
| 2012-08-07 | Karlan Beth Y (Director) | Option Ex | 942 | .00 | 0 |
| 2012-08-07 | Wasserman Stephen Edward (Director) | Option Ex | 942 | .00 | 0 |
| 2012-08-07 | Della Penta David T (Director) | Option Ex | 942 | .00 | 0 |
| 2012-08-07 | Timmins Rick (Director) | Option Ex | 942 | .00 | 0 |
| 2012-08-07 | Besbeck Steven M (Director) | Option Ex | 942 | .00 | 0 |
| 2012-08-07 | Voboril Edward F (Director) | Option Ex | 942 | .00 | 0 |
| 2012-06-30 | O'leary Richard A. (Corp. VP, HR & Admin.) | Option Ex | 562 | .00 | 0 |
| 2012-06-30 | Ginsburg Philip (Corp. VP, CMO) | Option Ex | 806 | .00 | 0 |
| 2012-06-30 | Warekois Tom E (Corp VP, Pres IRIS Diagnostics) | Option Ex | 808 | .00 | 0 |
| 2012-06-30 | Yi John U (Corp VP, Operations) | Option Ex | 489 | .00 | 0 |
| 2012-06-30 | Mello Robert A (Corp VP/Pres Sample Processing) | Option Ex | 489 | .00 | 0 |
| 2012-06-30 | Adams Thomas Phd (CTO & Corporate V.P.) | Option Ex | 292 | .00 | 0 |
| 2012-06-30 | Khalifa Amin I (CFO and Corporate V.P. Finance) | Option Ex | 952 | .00 | 0 |
| 2012-05-23 | Besbeck Steven M (Director) | Sale | 6,097 | 10.75 | 65,542 |
| 2012-05-22 | Besbeck Steven M (Director) | Sale | 8,900 | 11.21 | 99,724 |
| 2012-05-21 | Besbeck Steven M (Director) | Sale | 5,003 | 11.38 | 56,934 |
| 2012-05-21 | Besbeck Steven M (Director) | Option Ex | 20,000 | 3.01 | 60,199 |
| 2012-03-31 | Ginsburg Philip (Corp. VP, CMO) | Option Ex | 688 | .00 | 0 |
| 2012-03-31 | Warekois Tom E (Corp VP, Pres IRIS Diagnostics) | Option Ex | 292 | .00 | 0 |
| 2012-03-31 | Yi John U (Corp VP, Operations) | Option Ex | 209 | .00 | 0 |
| 2012-03-31 | Mello Robert A (Corp VP/Pres Sample Processing) | Option Ex | 209 | .00 | 0 |
| 2012-03-31 | Adams Thomas Phd (CTO & Corporate V.P.) | Option Ex | 292 | .00 | 0 |
| 2012-03-31 | Khalifa Amin I (CFO and Corporate V.P. Finance) | Option Ex | 951 | .00 | 0 |
| 2012-03-24 | Ginsburg Philip (Corp. VP, CMO) | Option Ex | 468 | .00 | 0 |
| 2012-03-24 | Warekois Tom E (Corp VP, Pres IRIS Diagnostics) | Option Ex | 2,062 | .00 | 0 |
| 2012-03-24 | Yi John U (Corp VP, Operations) | Option Ex | 1,125 | .00 | 0 |
| 2012-03-24 | Mello Robert A (Corp VP/Pres Sample Processing) | Option Ex | 1,125 | .00 | 0 |
| 2012-03-16 | O'leary Richard A. (Corp. VP, HR & Admin.) | Buy | 800 | 12.49 | 9,992 |
| 2012-03-15 | Yi John U (Corp VP, Operations) | Sale | 16,477 | 12.07 | 198,959 |
| 2012-03-15 | Yi John U (Corp VP, Operations) | Option Ex | 16,477 | 11.94 | 196,735 |
| 2012-03-14 | O'leary Richard A. (Corp. VP, HR & Admin.) | Option Ex | 2,250 | .00 | 0 |
| 2012-03-02 | Nadeau Richard G (Director) | Sale | 4,059 | 12.00 | 48,708 |
| 2012-03-02 | Nadeau Richard G (Director) | Option Ex | 4,059 | 3.01 | 12,217 |
| 2012-02-24 | Nadeau Richard G (Director) | Sale | 10 | 12.00 | 120 |
| 2012-02-24 | Nadeau Richard G (Director) | Option Ex | 10 | 3.01 | 30 |
| 2012-02-23 | Nadeau Richard G (Director) | Sale | 1,931 | 12.00 | 23,172 |
| 2012-02-23 | Nadeau Richard G (Director) | Option Ex | 1,931 | 3.01 | 5,812 |
| 2012-01-12 | Nadeau Richard G (Director) | Sale | 5,107 | 10.00 | 51,070 |
| 2012-01-12 | Nadeau Richard G (Director) | Option Ex | 5,107 | 3.01 | 15,372 |
| 2012-01-11 | Nadeau Richard G (Director) | Sale | 2,893 | 10.00 | 28,930 |
| 2012-01-11 | Nadeau Richard G (Director) | Option Ex | 2,893 | 3.01 | 8,707 |
| 2011-12-31 | Ginsburg Philip (Corp. VP, CMO) | Option Ex | 688 | .00 | 0 |
| 2011-12-31 | Warekois Tom E (Corp VP, Pres IRIS Diagnostics) | Option Ex | 293 | .00 | 0 |
| 2011-12-31 | Yi John U (Corp VP, Operations) | Option Ex | 209 | .00 | 0 |
| 2011-12-31 | Mello Robert A (Corp VP/Pres Sample Processing) | Option Ex | 209 | .00 | 0 |
| 2011-12-31 | Adams Thomas Phd (CTO & Corporate V.P.) | Option Ex | 293 | .00 | 0 |
| 2011-12-12 | Garcia Cesar M (President and CEO) | Option Ex | 86,105 | 2.60 | 223,873 |
| 2011-11-11 | Khalifa Amin I (CFO and Corporate V.P. Finance) | Option Ex | 3,807 | .00 | 0 |
| 2011-09-30 | Warekois Tom E (Corp VP, Pres IRIS Diagnostics) | Option Ex | 292 | .00 | 0 |
| 2011-09-30 | Yi John U (Corp VP, Operations) | Option Ex | 209 | .00 | 0 |
| 2011-09-30 | Mello Robert A (Corp VP/Pres Sample Processing) | Option Ex | 209 | .00 | 0 |
| 2011-09-30 | Adams Thomas Phd (CTO & Corporate V.P.) | Option Ex | 292 | .00 | 0 |
| 2011-08-28 | Ginsburg Philip (Corp. VP, CMO) | Option Ex | 2,753 | .00 | 0 |
| 2011-08-11 | Yi John U (Corp VP, Operations) | Sale | 5,790 | 8.43 | 48,786 |
| 2011-08-10 | Yi John U (Corp VP, Operations) | Sale | 3,100 | 8.30 | 25,730 |
| 2011-06-30 | Warekois Tom E (Corp VP, Pres IRIS Diagnostics) | Option Ex | 293 | .00 | 0 |
| 2011-06-30 | Yi John U (Corp VP, Operations) | Option Ex | 209 | .00 | 0 |
| 2011-06-30 | Mello Robert A (Corp VP/Pres Sample Processing) | Option Ex | 209 | .00 | 0 |
| 2011-06-30 | Adams Thomas Phd (CTO & Corporate V.P.) | Option Ex | 293 | .00 | 0 |
| 2011-06-16 | Adams Thomas Phd (CTO & Corporate V.P.) | Sale | 20,000 | 9.25 | 185,040 |
| 2011-06-10 | Yi John U (Corp VP, Operations) | Sale | 5,000 | 8.97 | 44,830 |
| 2011-05-23 | Besbeck Steven M (Director) | Sale | 20,000 | 8.89 | 177,760 |
| 2011-05-23 | Besbeck Steven M (Director) | Option Ex | 20,000 | 2.00 | 40,000 |
| 2011-03-23 | Warekois Tom E (Corp VP, Pres IRIS Diagnostics) | Option Ex | 1,169 | .00 | 0 |
| 2011-03-23 | Yi John U (Corp VP, Operations) | Option Ex | 835 | .00 | 0 |
| 2011-03-23 | Mello Robert A (Corp VP/Pres Sample Processing) | Option Ex | 835 | .00 | 0 |
| 2011-03-23 | Adams Thomas Phd (CTO & Corporate V.P.) | Option Ex | 1,169 | .00 | 0 |
| 2010-12-03 | Khalifa Amin I (CFO and Corporate V.P. Finance) | Buy | 1,000 | 9.67 | 9,673 |
| 2010-11-04 | Ginsburg Philip (Corp. VP, CMO) | Buy | 2,700 | 9.85 | 26,595 |
| 2010-08-23 | Della Penta David T (Director) | Buy | 6,500 | 7.63 | 49,608 |
| 2010-08-23 | Voboril Edward F (Director) | Buy | 5,000 | 7.69 | 38,430 |
| 2010-08-18 | Yi John U (Corp VP, Operations) | Sale | 12,500 | 7.65 | 95,612 |
Insider trading activities including stock purchases, stock sales, and option exercises of IRI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Iris International Inc (symbol IRI, CIK number 319240) see the Securities and Exchange Commission (SEC) website.